2024
ASO Visual Abstract: Clipping the Positive Lymph Node in Patients with Clinically Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical Trial
Switalla K, Boughey J, Dimitroff K, Yau C, Ladores V, Yu H, Tchou J, Golshan M, Ahrendt G, Postlewait L, Piltin M, Reyna C, Matsen C, Tuttle T, Wallace A, Arciero C, Lee M, Tseng J, Son J, Rao R, Sauder C, Naik A, Howard-McNatt M, Lancaster R, Norwood P, Esserman L, Mukhtar R. ASO Visual Abstract: Clipping the Positive Lymph Node in Patients with Clinically Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical Trial. Annals Of Surgical Oncology 2024, 1-2. PMID: 39138776, DOI: 10.1245/s10434-024-15965-8.Peer-Reviewed Original Research
2021
Exploring the impact of exercise and mind–body prehabilitation interventions on physical and psychological outcomes in women undergoing breast cancer surgery
Knoerl R, Giobbie-Hurder A, Sannes TS, Chagpar AB, Dillon D, Dominici LS, Frank ES, Golshan M, McTiernan A, Rhei E, Tolaney SM, Winer EP, Yung RL, Irwin ML, Ligibel JA. Exploring the impact of exercise and mind–body prehabilitation interventions on physical and psychological outcomes in women undergoing breast cancer surgery. Supportive Care In Cancer 2021, 30: 2027-2036. PMID: 34648061, DOI: 10.1007/s00520-021-06617-8.Peer-Reviewed Original ResearchConceptsCancer treatment-related symptomsPrehabilitation interventionsTreatment-related symptomsTime of enrollmentImpact of exerciseQuality of lifeBreast cancerGroup participantsPre-operative exerciseBreast cancer surgeryMind-body interventionsCognitive functioningOpportunity trialCancer surgeryOutcome measuresSecondary analysisOne monthSurgeryMeasures of qualityGroup comparisonsCancer diagnosisCancerWomenInterventionSignificant differencesCorrection to: Prediction of Persistent Pain Severity and Impact 12 Months After Breast Surgery Using Comprehensive Preoperative Assessment of Biopsychosocial Pain Modulators
Schreiber KL, Zinboonyahgoon N, Mikayla Flowers K, Hruschak V, Fields KG, Patton ME, Schwartz E, Azizoddin D, Soens M, King T, Partridge A, Pusic A, Golshan M, Edwards RR. Correction to: Prediction of Persistent Pain Severity and Impact 12 Months After Breast Surgery Using Comprehensive Preoperative Assessment of Biopsychosocial Pain Modulators. Annals Of Surgical Oncology 2021, 28: 896-896. PMID: 34401990, DOI: 10.1245/s10434-021-10658-y.Peer-Reviewed Original ResearchSurvival Benefits Associated with Surgery in Patients with Metastatic Breast Cancer by Breast Cancer Subtype
Han H, . T, Yu J, Golshan M, Hsu H, Chu C, Hong Z, Fu C, Chou Y, Dai M, Liao G. Survival Benefits Associated with Surgery in Patients with Metastatic Breast Cancer by Breast Cancer Subtype. Journal Of Cancer Science And Clinical Therapeutics 2021, 05 DOI: 10.26502/jcsct.5079127.Peer-Reviewed Original Research
2017
170P Impact of neoadjuvant therapy (NT) and pathological complete response (pCR) on breast-conserving surgery (BCS) in patients (pts) with breast cancer (BC): A meta-analysis
Criscitiello C, Golshan M, Barry W, Viale G, Wong S, Santangelo M, Curigliano G. 170P Impact of neoadjuvant therapy (NT) and pathological complete response (pCR) on breast-conserving surgery (BCS) in patients (pts) with breast cancer (BC): A meta-analysis. Annals Of Oncology 2017, 28: v50-v51. DOI: 10.1093/annonc/mdx362.020.Peer-Reviewed Original ResearchImplementation of surgeon-initiated Oncotype DX ordering among patients with breast cancer to reduce chemotherapy wait times.
Losk K, Freedman R, Lin N, Golshan M, Lester S, Pochebit S, Natsuhara K, Camuso K, King T, Bunnell C. Implementation of surgeon-initiated Oncotype DX ordering among patients with breast cancer to reduce chemotherapy wait times. Journal Of Clinical Oncology 2017, 35: 166-166. DOI: 10.1200/jco.2017.35.8_suppl.166.Peer-Reviewed Original ResearchOncotype DX testingChemotherapy initiationMedical oncologistsBreast cancerConsecutive breast cancer patientsAdjuvant chemotherapy initiationBreast cancer patientsOncotype DX resultsPathology reviewClinical outcomesTumor characteristicsMedical oncologyOncotype DXCancer patientsPatient satisfactionSurgery dateSurgical oncologyPatientsTurnaround timeSurgeryIntervention implementationMean timeOncologistsSignificant reductionOrder date
2013
Magnetic Resonance Imaging-Guided Breast Intervention and Surgery
Gombos E, Kacher D, Caragacianu D, Jayender J, Golshan M. Magnetic Resonance Imaging-Guided Breast Intervention and Surgery. 2013, 817-844. DOI: 10.1007/978-1-4614-7657-3_62.Peer-Reviewed Original ResearchMagnetic resonance imagingBreast magnetic resonance imagingResonance imagingContrast-enhanced breast magnetic resonance imagingBreast interventionsImportant adjunctive modalityMalignant breast diseaseConventional imaging modalitiesDetection of malignancySuspicious breast lesionsPhysical examinationBreast diseaseBreast cancerAdjunctive modalityCases MRTherapeutic methodsTissue samplingBreast lesionsIntraoperative imagingImaging modalitiesMargin assessmentMRI guidancePeer-reviewed dataSurgeryMargin evaluationReducing breast cancer chemotherapy treatment delays by improving the transition from surgical to medical oncology.
Losk K, Kadish S, Golshan M, Lin N, Hirshfield-Bartek J, Cutone L, Bunnell C, Weingart S. Reducing breast cancer chemotherapy treatment delays by improving the transition from surgical to medical oncology. Journal Of Clinical Oncology 2013, 31: 51-51. DOI: 10.1200/jco.2013.31.31_suppl.51.Peer-Reviewed Original ResearchInitiation of chemotherapyBreast cancer patientsMedical oncologyOncology followDefinitive surgeryCancer patientsConsecutive breast cancer patientsChemotherapy treatment delaysAdverse clinical outcomesBreast cancer careTransitions of careProcess of careAdjuvant chemotherapyTimely chemotherapyMedical oncologistsClinical outcomesTreatment delayBreast surgeryCancer careInitial consultationBreast surgeonsCare coordinationChemotherapySurgeryMultidisciplinary team